Thyrotoxicosis-associated Wernicke's encephalopathy

Journal of General Internal Medicine

Volumn 23, Issue 6, 2008, Pages 897-

  Sechi, GianPietro ^a  

^a Neurological Clinic   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THIAMINE;

CLINICAL PRACTICE; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; LETTER; PROPHYLAXIS; THYROTOXICOSIS; WERNICKE ENCEPHALOPATHY;

HUMANS; STARVATION; THIAMINE; THIAMINE DEFICIENCY; THYROTOXICOSIS; WERNICKE ENCEPHALOPATHY;

EID: 43949100982     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0595-z     Document Type: Letter

References (3)

1. Bonucchi J, Hassan I, Policeni B, Kaboli P. Thyrotoxicosis-associated Wernicke's encephalopathy. J Gen Intern Med. 2008;23:106-9.
2. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6:442-55.
3. Tallaksen CM, Sande A, Bohmer T, Bell H, Karlsen J. Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol. 1993;44:73-8.